647 results on '"Irving, Julie"'
Search Results
2. Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
3. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
4. Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
5. Diseases of the Peritoneum
6. Nonneoplastic Lesions of the Ovary
7. Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas
8. Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial
9. PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107
10. Diagnostic Flow Cytometry and Immunophenotypic Classification
11. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
12. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
13. Corrigendum to “Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death”: [Modern Pathology 36 (2023) 100085]
14. Reducing post mastectomy seroma using closed incision negative pressure wound therapy
15. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
16. Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
17. Alignment of a High-Ranked PISA Mathematics Curriculum and the 'Parallel Curriculum' for Gifted Students: Is a High PISA Mathematics Ranking Indicative of Curricular Suitability for Gifted Learners?
18. Data from Potent, Selective Inhibitors of Fibroblast Growth Factor Receptor Define Fibroblast Growth Factor Dependence in Preclinical Cancer Models
19. Supplementary Methods, Figures 1-4, Tables 1-2 from Potent, Selective Inhibitors of Fibroblast Growth Factor Receptor Define Fibroblast Growth Factor Dependence in Preclinical Cancer Models
20. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
21. Supplementary Table 4 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
22. Supplementary Table from Loss of Heterozygosity and Somatic Mutations of the Glucocorticoid Receptor Gene Are Rarely Found at Relapse in Pediatric Acute Lymphoblastic Leukemia but May Occur in a Subpopulation Early in the Disease Course
23. Supplementary Table 3 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
24. Supplementary Table 1 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
25. Supplementary Table 2 from Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia
26. High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker
27. Managing No-Drain Mastectomy with Closed Incision Negative Pressure Wound Therapy using Full-Coverage Foam Dressings
28. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia
29. The ability to cross the blood–cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts
30. Acute lymphoblastic leukemia in the context of RASopathies
31. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations
32. Diseases of the Peritoneum
33. Nonneoplastic Lesions of the Ovary
34. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
35. Hyperactive CREB subpopulations increase during therapy in paediatric B lineage acute lymphoblastic leukaemia
36. Dual Targeting of MDM2 and BCL2/Bclxl Demonstrates Potent Synergistic Activity in High-Risk Adult Acute Lymphoblastic Leukemia
37. Identification of Minimal Residual Disease in B-Acute Lymphoblastic Leukaemia Using Uniform Manifold Approximation Projection
38. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
39. Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia
40. 60: Does a Subspecialty Gynecologic Pathology Review Change Management of Endometrial Cancer Patients: A BC Cancer- Victoria Experience
41. A Metacognitive Portrait of Gifted Learners
42. Prevention of Relapse/Recurrence in Major Depressive Disorder With Either Mindfulness-Based Cognitive Therapy or Cognitive Therapy
43. Ovarian Microcystic Stromal Tumors Are Characterized by Alterations in the Beta-Catenin-APC Pathway and May be an Extracolonic Manifestation of Familial Adenomatous Polyposis
44. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
45. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications
46. Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification
47. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription–polymerase chain reaction in formalin-fixed, paraffin-embedded tumor
48. Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial
49. Integrated care pathway for co‐occurring major depressive and alcohol use disorders: Outcomes of the first two years
50. Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.